HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Abstract
Although well studied in settings of helminth infection and allergen sensitization, the combined contributions of IL-4 and IL-13 and their signaling pathways in models of viral pathogenesis have not been reported. Using a murine model of respiratory syncytial virus (RSV) infection, we evaluated the contribution of IL-13, alone and in conjunction with IL-4, during immunization with recombinant vaccinia virus expressing RSV G glycoprotein (vvGs) or with formalin-inactivated RSV (FI-RSV). We showed that both IL-4 and IL-13 activity must be inhibited to modulate G-specific responses resulting in severe RSV-induced disease. Inhibition of IL-4 or IL-13 activity alone had minimal impact on disease in vvGs-immunized mice. However, treatment of IL-4-deficient mice with IL-13Ra during vvGs immunization reduced IL-5, IL-13, and eotaxin production and pulmonary eosinophilia after RSV challenge. In contrast, FI-RSV-induced immune responses were diminished when either IL-4 or IL-13 activity was blocked. After RSV challenge, these type 2 T cell responses were also diminished in vvGs-primed IL-4Ralpha-deficient mice. Our data suggest that secreted vvGs uses mechanisms requiring signaling through the IL-4Ralpha-chain by either IL-4 or IL-13 for induction of eosinophilia and is the first description of the relative contributions of IL-4, IL-13, and their receptors in viral pathogenesis.
AuthorsTeresa R Johnson, Robert A Parker, Joyce E Johnson, Barney S Graham
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 170 Issue 4 Pg. 2037-45 (Feb 15 2003) ISSN: 0022-1767 [Print] United States
PMID12574374 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Viral
  • Cytokines
  • HN Protein
  • Interleukin-13
  • Receptors, Interleukin-4
  • Respiratory Syncytial Virus Vaccines
  • Vaccines, Inactivated
  • Viral Envelope Proteins
  • attachment protein G
  • Formaldehyde
  • Interleukin-4
Topics
  • Animals
  • Antibodies, Viral (metabolism)
  • Antibody Specificity
  • Cell Line
  • Cytokines (biosynthesis)
  • Formaldehyde (pharmacology)
  • HN Protein (immunology)
  • Humans
  • Immunization
  • Inflammation (immunology, virology)
  • Interleukin-13 (antagonists & inhibitors, physiology)
  • Interleukin-4 (antagonists & inhibitors, physiology)
  • Lung (immunology, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Neutralization Tests
  • Pulmonary Eosinophilia (immunology, pathology, virology)
  • Receptors, Interleukin-4 (deficiency, genetics)
  • Respiratory Syncytial Virus Infections (immunology, pathology, virology)
  • Respiratory Syncytial Virus Vaccines (administration & dosage, immunology)
  • Respiratory Syncytial Viruses (immunology)
  • Th2 Cells (immunology, metabolism)
  • Vaccines, Inactivated (administration & dosage, immunology)
  • Vaccinia virus (immunology)
  • Viral Envelope Proteins
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: